Clinical Trial Update: Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS Study

View source ↗

Summary

The PREDIGS trial update suggests procalcitonin may indicate early dehiscence after gastric cancer surgery. This biomarker finding could inform postoperative mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Gastric Cancer | Status: UNKNOWN